Home | Business News | Browse by Publication | P | PR Newswire

Preliminary Phase I/II Data Show Lucentis(TM) in Combination With Visudyne(R) Maintained or Improved Vision in Approximately 90 Percent of Patients With Wet Age-Related Macular Degeneration.

Publication: PR Newswire
Publication Date: 31-MAY-05
Format: Online - approximately 1339 words
Delivery: Immediate Online Access

Article Excerpt
SOUTH SAN FRANCISCO, Calif., May 31 /PRNewswire-FirstCall/ -- Genentech, Inc. announced today that a single-masked Phase I/II clinical study of the investigational drug Lucentis(TM) (ranibizumab) met its primary efficacy endpoint of maintaining vision in patients with wet age-related macular degeneration (AMD) when used in combination with verteporfin (Visudyne(R)) photodynamic therapy (PDT). Approximately 90 percent of patients maintained or improved vision (defined as a loss of less than 15 letters in visual acuity) when treated with the combination of Lucentis and PDT compared to approximately 68 percent of those treated in the control arm of PDT alone (p = 0.0003). Patients treated with Lucentis plus PDT at 12 months had, on average, a significant improvement in visual acuity compared to visual acuity at study entry, an important secondary endpoint, while the PDT-alone group demonstrated a decrease in mean visual acuity from baseline to 12 months. One-year data from the trial will be presented at the 23rd Annual Meeting of the American Society of Retina Specialists (ASRS), July 16 to 20 in Montreal, Canada.

A preliminary analysis of the data showed there was an increased risk of the serious ocular adverse event uveitis in patients treated with Lucentis in combination with PDT...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
LivePerson to Showcase Industry Solutions at Internet Retailer 2005 Co..., May 31, 2005
Raytheon Features Integrated Mission Solutions for a Net-Enabled World..., May 31, 2005
Patni Computer Systems Strengthens Financial Services Executive Team., May 31, 2005
Competitive Athlete Training Zone (CATZ) to Create a National Franchis..., May 31, 2005
Dynamic Mutual Funds Becomes First Investment Company to Sign for ADP'..., May 31, 2005

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.